Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable Angina: Results of a Veterans Administration Cooperative Study

New England Journal of Medicine

Volumn 309, Issue 7, 1983, Pages 396-403

  Lewis, H Daniel ^a   Davis, James W ^a   Archibald, Donald G ^a   Steinke, William E ^a   Smitherman, Thomas C ^a   Doherty, James E ^a   Schnaper, Harold W ^a   Lewinter, Martin M ^a   Linares, Esteban ^a   Pouget, J Maurice ^a   Sabharwal, Subhash C ^a   Chesler, Elliot ^a   Demots, Henry ^a  

^a Veterans Administration Central Office   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO;

CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DIGESTIVE SYSTEM; DIGESTIVE SYSTEM INJURY; DOUBLE BLIND PROCEDURE; DRUG THERAPY; ELECTROCARDIOGRAPHY; FATALITY; GASTROINTESTINAL TOXICITY; HEART; HEART INFARCTION; HUMAN; INTOXICATION; Q WAVE; RANDOMIZED CONTROLLED TRIAL; THERAPY;

ADRENERGIC BETA-ANTAGONISTS; ANGINA PECTORIS; ASPIRIN; CLINICAL TRIALS; DEATH, SUDDEN; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HUMANS; MALE; MYOCARDIAL INFARCTION; PATIENT COMPLIANCE; PILOT PROJECTS; RANDOM ALLOCATION;

EID: 0020528647     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198308183090703     Document Type: Article

References (37)

1. Harker LA, Ritchie JL. The role of platelets in acute vascular events. Circulation 1980; 62: Supplement 5: V-13–V-18.
2. Fuster V, Chesebro JH. Antithrombotic therapy: role of platelet-inhibitor drugs. Mayo Clin Proc 1981; 56: 102–112.
3. Fuster V, Chesebro JH. Antithrombotic therapy: role of platelet-inhibitor drugs. Mayo Clin Proc 1981; 56: 185–195.
4. Fuster V, Chesebro JH. Antithrombotic therapy: role of platelet-inhibitor drugs. Mayo Clin Proc 1981; 56: 265–273.
5. Masen A, Chierchia S, L'Abbate A. Pathogenetic mechanisms underlying the clinical events associated with atherosclerotic heart disease. Circulation 1980; 62: Supplement 5: V-3–V-13.
6. Moneada S, Vane JR. Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. N Engl J Med 1979; 300: 1142–1147.
7. Elwood PC, Cochrane AL, Burr ML, et al. A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction. Br Med J 1974; 1: 436–440.
8. Coronary Drug Project Research Group. Aspirin in coronary heart disease. J Chronic Dis 1976; 29: 625–642.
9. Breddin K, Loew D, Lechner K, Überla K, Walter E. Secondary prevention of myocardial infarction: comparison of acetylsalicylic acid, phenprocoumon and placebo: a multicenter two-year prospective study. Thromb Haemostas 1979; 41: 225–236.
10. Elwood PC, Sweetnam PM. Aspirin and secondary mortality after myocardial infarction. Lancet 1979; 2: 1313–1315.
11. Aspirin Myocardial Infarction Study Research Group. A randomized, controlled trial of aspirin in persons recovered from myocardial infarction. JAMA 1980; 243: 661–669.
12. Persantine-Aspirin Reinfarction Study Research Group. Persantine and aspirin in coronary heart disease. Circulation 1980; 62: 449–461.
13. Gazes PC, Mobley EM Jr., Farris HM Jr., Duncan RC, Humphries GB. Preinfarction (unstable) angina — a prospective study — ten year follow-up. Circulation 1973; 48: 331–337.
14. Neill WA, Wharton TP Jr., Fluri-Lundeen J, Cohen IS. Acute coronary insufficiency — coronary occlusion after intermittent ischemic attacks. N Engl J Med 1980; 302: 1157–1162.
15. Smitherman TC, Hillert MC Jr., Narahara KA, et al. Evidence for transient limitations in coronary blood flow during unstable angina pectoris: hemodynamic changes with spontaneous pain at rest versus exercise-induced ischemia following stabilization of angina. Clin Cardiol 1980; 3: 309–316.
16. Chierchia S, Brunelli C, Simonetti I, Lazzari M, Maseri A. Sequence of events in angina at rest: primary reduction in coronary flow. Circulation 1980;61: 759–768.
17. Leonards JR, Levy G. Reduction or prevention of aspirin-induced occult gastrointestinal blood loss in man. Clin Pharmacol Ther 1969; 10: 571–575.
18. Criteria Committee of the New York Heart Association. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 8th ed. Boston: Little, Brown, 1979: 290.
19. Davis JW, Phillips PE, Yue KTN, Lewis HD Jr., Hartman CR. Platelet aggregation: adult-onset diabetes mellitus and coronary artery disease. JAMA 1978; 239: 732–734.
20. Roe CR, Limbird LE, Wagner GS, Nerenberg ST. Combined isoenzyme analysis in the diagnosis of myocardial injury: application of electrophoretic methods for the detection and quantitation of the creatine phosphokinase MB isoenzyme. J Lab Clin Med 1972; 80: 577–590.
21. Wagner GS, Roe CR, Limbird LE, Rosati RA, Wallace AG. The importance of identification of the myocardial-specific isoenzyme of creatine phosphokinase (MB form) in the diagnosis of acute myocardial infarction. Circulation 1973; 47: 263–269.
22. Smitherman TC, Lewis HD Jr., Archibald DG, LeWinter MM, Steinke WE. Diagnosis (Dx) of new myocardial infarction (MI) by Minnesota Code (MC) with serial electrocardiograms (ECG) after unstable angina. Circulation 1981; 64: Supplement 4: IV-42. abstract.
23. Walker SH, Duncan DB. Estimation of the probability of an event as a function of several independent variables. Biometrika 1967; 54: 167–179.
24. Cutler SJ, Ederer F. Maximum utilization of the life table method in analyzing survival. J Chronic Dis 1958; 8: 699–712.
25. Canner PL. Monitoring treatment differences in long-term clinical trials. Biometrics 1977;33: 603–615.
26. Archibald DG. Monitoring of ongoing studies: proceedings of the VA Cooperative Studies Program symposium, Chicago, August 18–19, 1977. Aberdeen, Md.: Aberdeen Proving Ground, 1977:79–88.
27. Armitage P. Sequential medical trials. 2nd ed. New York: John Wiley, 1975: 44.
28. Fields WS, Lemak NA, Frankowski RF, Hardy RJ. Controlled trial of aspirin in cerebral ischemia. Stroke 1977; 8: 301–316.
29. Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 1978; 299: 53–59.
30. Bousser MG, Eschwege E, Haguenau M, et al. “AICLA” controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Stroke 1983; 14: 5–14.
31. Smitherman TC, Milam M, Woo J, Willerson JT, Frenkel EP. Elevated beta thromboglobulin in peripheral venous blood of patients with acute myocardial ischemia: direct evidence for enhanced platelet reactivity in vivo. Am J Cardiol 1981; 48: 395–402.
32. Hirsh PD, Hillis LD, Campbell WB, Firth BG, Willerson JT. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med 1981; 304: 685–691.
33. Folts JD, Crowell EB Jr., Rowe GG. Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation 1976; 54: 365–370.
34. Duncan B, Fulton M, Morrison SL, et al. Prognosis of new and worsening angina pectoris. Br Med J 1976; 1: 981–985.
35. Heng M-K, Norris RM, Singh BN, Partridge JB. Prognosis in unstable angina. Br Heart J 1976; 38: 921–925.
36. Mulcahy R, Daly L, Graham I, et al. Unstable angina: natural history and determinants of prognosis. Am J Cardiol 1981; 48: 525–528.
37. Alison HW, Russell RO Jr., Mantle JA, Kouchoukos NT, Moraski RE, Rackley CE. Coronary anatomy and arteriography in patients with unstable angina pectoris. Am J Cardiol 1978; 41: 204–209.